Superworth

Bluejay Diagnostics price to book ratio BJDX

Market value divided by the book value of the company's net assets, since 2022.

Today, Nov 2, 2026
0.1×
5-year median
0.1×
Against its 5-year history
15th
percentile: 0 is its lowest day, 100 its highest
5-year range
0.0× to 0.4×
Peer median
0.3×

Bluejay Diagnostics' price to book ratio is 0.1× as of Nov 2, 2026.

That is below its 5-year median of 0.1×, lower than on 85% of days in the last 5 years.

Over that time it ranged from 0.0× in Aug 2024 to 0.4× in Jul 2022.

The median for 10 medical instruments and supplies stocks of a similar size is 0.3×.

Price to book ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far0.1×0.1×0.3×
20250.1×0.0×0.2×
20240.1×0.0×0.2×
20230.1×0.1×0.3×
20220.1×0.1×0.4×

Against its peers

Companies in Medical - Instruments & Supplies nearest Bluejay Diagnostics' size, closest first, today.

CompanyPrice to book ratio
BJDXBluejay Diagnostics0.1×
VJETFlyte Aviation0.0×
PFSAProfusan/m
IVFINVO Fertility0.1×
BBLGBone Biologics0.2×
TNONTenon Medicaln/m
AMIXAutonomix Medical0.5×
NXGLNexgel0.4×
ADGMAdagio Medicaln/m
GCTKGlucotrackn/m
XAIRBeyond Air1.1×
Peer median0.3×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on Bluejay Diagnostics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.